Goldman Sachs
NUTX

Goldman Sachs’s Nutex Health NUTX Stock Holding History

Goldman Sachs’s Portfolio NUTX Stock Details NUTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$8.76M Buy
51,244
+17,449
+52% +$2.21M ﹤0.01% 3361
2026
Q1 		$3.21M Buy
33,795
+14,508
+75% +$1.78M ﹤0.01% 4115
2025
Q4 		$3.18M Sell
19,287
-10,160
-35% -$1.35M ﹤0.01% 4177
2025
Q3 		$3.04M Buy
29,447
+18,397
+166% +$1.8M ﹤0.01% 4100
2025
Q2 		$1.38M Sell
11,050
-7,069
-39% -$913K ﹤0.01% 4468
2025
Q1 		$852K Buy
18,119
+2,748
+18% +$134K ﹤0.01% 4815
2024
Q4 		$487K Buy
+15,371
New +$438K ﹤0.01% 5268
2024
Q1 		– Sell
-263
Closed -$7.09K – 5774
2023
Q4 		$7.09K Sell
263
-1,689
-87% -$52.7K ﹤0.01% 5502
2023
Q3 		$59.3K Sell
1,952
-4,055
-68% -$196K ﹤0.01% 5257
2023
Q2 		$380K Buy
6,007
+5,314
+767% +$456K ﹤0.01% 4882
2023
Q1 		$105K Sell
693
-41
-6% -$8.3K ﹤0.01% 5452
2022
Q4 		$209K Buy
734
+356
+94% +$68.4K ﹤0.01% 5283
2022
Q3 		$85K Sell
378
-6,313
-94% -$2.68M ﹤0.01% 5722
2022
Q2 		$3.24M Buy
+6,691
New +$7.89M ﹤0.01% 3602

Other funds holding NUTX

PP
Pertento Partners London, United Kingdom $1.86B AUM 53.86% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
American Century Companies
American Century Companies Kansas City, Missouri $226B AUM 44.75% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
WC
Winmill & Co Walpole, New Hampshire $452M AUM 56.84% 1-Year Est. Return
Focus Partners Wealth
Focus Partners Wealth Boston, Massachusetts $97.6B AUM 29.43% 1-Year Est. Return

Goldman Sachs's NUTX Position: Q2 2026 in Review

Goldman Sachs increased its Nutex Health (NUTX) stake by 52% in Q2 2026, buying an estimated $2.21M and bringing the position to 51,244 shares worth $8.76M. The position accounts for ﹤0.01% of the portfolio, ranked #3361.

Goldman Sachs first reported a position in NUTX in Q2 2022 and has held it in 14 quarters since. 154 funds tracked by Wall St. Rank hold NUTX as of Q2 2026.

  • Goldman Sachs held 51,244 shares of Nutex Health worth $8.76M as of Q2 2026.
  • Goldman Sachs bought 17,449 Nutex Health shares in Q2 2026, an estimated $2.21M.
  • Nutex Health made up ﹤0.01% of Goldman Sachs's portfolio in Q2 2026, its #3361 holding.
  • Goldman Sachs first reported a position in Nutex Health in Q2 2022 and has held it in 14 quarters since.
  • 154 funds tracked by Wall St. Rank held Nutex Health as of Q2 2026.

Based on Goldman Sachs's 13F filing for Q2 2026, filed 14 Aug 2026.